Neuronetics, Inc. · NASDAQ:STIM
Neuronetics — William Blair 44th Annual Growth Stock Conference 2024
18 slides from Neuronetics's conference presentation, Jun 6, 2024
Slide 1: William Blair 44th Annual Growth Stock Conference
Exhibit 99.1 William Blair th 44 Annual Growth Stock Conference June 6, 2024
Slide 2: Safe harbor statement
“Safe harbor” statement under the Private Securities Litigation Reform Act of 1995: Statements in this presentation regarding Neuronetics, Inc. (the “Company”) that are not historical facts constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of
Slide 3: Agenda
Agenda ◼ NeuroStar Patient Trends ◼ Better Me Provider Program ◼ Adolescent Indication Launch ◼ Road to Profitability Company Confidential 3
Slide 4: Weekly New Patient Starts by Month
Weekly New Patient Starts by Month 600 500 400 300 200 100 - Company Confidential 4
Slide 5: Weekly New Patient Starts by Customer Type
Weekly New Patient Starts by Customer Type Up +22% YTD 275 250 225 200 175 150 125 100 75 50 25 - Local Consumables Company Confidential 5
Slide 6: NSU Attendees Help More Patients Receive Treatment
NSU Attendees Help More Patients Receive Treatment 58% Greater Utilization for NSU Attendees Practices that attend NSU consistently outperform practices that do not on a month-to-month basis. In March 2024, NSU practices performed 58% better over baseline Jan 2022 data, than sites that have not atte
Slide 7: Change Healthcare Cyber Attack Impact on Customers
Change Healthcare Cyber Attack More than Half of our Customers were Impacted Has your practice been impacted by the How has your practice been impacted Change Healthcare cyber attack? by the Change Healthcare cyber attack? 54% 40% 24% 22% 60% NO YES TMS TMS TMS Prior-authorizations Patient Starts Re
Slide 8: NeuroStar Better Me Provider Pilot Program
NeuroStar Better Me Provider Pilot Program 222 Providers are participants required to: in pilot * Clinical evidence demonstrates superior outcomes for patients who complete a course of NeuroStar therapy compared to those who do not complete treatment. However, the actual number of sessions performed
Slide 9: BMP Raises the Bar for Patient Response Time
BMP Raises the Bar for Patient Response Time BMP Non-BMP Active BMP PHQ-10s (Inside the Practice) Committed Rate of Successful Follow-up 13% 46% 78% (1 Business Day) BMP Non-BMP Active BMP NPL Leads (Outside the Practice) Committed Rate of Successful Follow-up 14% 58% 90% (1 Business Day) Phase 2: F
Slide 10: BMP Practices Transform the Lives of More Patients
Following the 5-Standards, BMP Practices Transform the Lives of More Patients Avg New MT’s BMP Status Per Site for Q1 2024 Non-BMP Provider 3.0 Committed BMP Provider 7.3 Active BMP Provider 10.7 * Sites included were active as of Q1 2024 Company Confidential 10
Slide 11: BMP Practices are Helping Patients Faster
BMP Practices are Helping Patients Faster Q1 2023 Q1 2024 82 days 17 days 5x Faster from potential patient interest to MT All patient interest in Local Consumable Offices; Phase 2: Feb 1, 2024 – Apr 7, 2024 vs. PY Company Confidential 11
Slide 12: Adolescent Launch
Adolescent Launch 12
Slide 13: New Opportunity with Adolescent Psychiatrists
New Opportunity with Adolescent Psychiatrists New Customers 1,100+ Existing Customers Supported by Supported by 17 Capital Sales Representatives 45 Practice Development Managers • Expanded opportunity • Increases the value of NeuroStar system by broadening label to • 8,000+ adolescent and additional
Slide 14: NeuroStar is Actively Driving Consumer Awareness
NeuroStar is Actively Driving Consumer Awareness Hosted Adolescent-Focused Media Event in NYC May 15, 2024 PR 22 articles & 60M+ reach to date • 120%+ Google search lift • 30+ social posts reaching 1.4M • 2 articles within 1 week Actual NeuroStar Digital Social Patient and Mom Ads Media Evaluating C
Slide 15: The NeuroStar Q2 Summit was the largest since inception
The Neurostar Q2 Summit was the largest since inception May 17-18, 2024 The Westin Kierland, Scottsdale AZ Day 1 Day 2 • Technology Overview• Clinical • Operationalizing• Marketing • System Demo• Reimbursement PANEL OF EXPERTS 50% of systems sold to adolescent-focused practices! Brian Banks, CNP Sob
Slide 16: Road to Profitability
Road to Profitability
Slide 17: Operating Expense Trends
Dollars in $000 Operating Expense Trends Variance Increase/(decrease) Operating Expenses as % of Revenue 140% 120% 130% -3% YOY 115% Change -4% 100% YOY 100% Change 80% 60% 40% 20% 0 2022 2023 2024* Full Year Operating Expenses $84,834 $82,259 $79,000* Company Confidential 17
Slide 18: We Expect our Focused Strategies to Continue Building Momentum
We Expect our Focused Strategies to Continue Building Momentum ◼ Achieved record results in Q1 ◼ Better Me Provider Program key performance indicators: Ÿ Raises the bar for response time Ÿ Helps people in need 5x faster ◼ Generated awareness for adolescent indication among over 1.5 Million people ◼
Neuronetics — William Blair 44th Annual Growth Stock Conference 2024 on 6ix